Author

Eugenie Ankowitsch

Eugenie Ankowitsch Published: February 16th, 2022

EU Parliament votes on own-initiative report on cancer prevention

Fair access to cancer screening, diagnosis, and treatment, the promotion of cross-border research, stricter measures against tobacco, new regulations on e-cigarettes, and warning labels on alcoholic beverages: These are the key demands in the report of the Special Committee on Beating Cancer (BECA), which the EU Parliament discussed and voted on yesterday. The chances of surviving cancer in […]

Eugenie Ankowitsch Published: February 11th, 2022

AI regulation: study calls for coherence

Regulation in the digital sector in Europe lacks coherence. This is shown by a study commissioned by the AI Special Committee (AIDA). In the search for a balance between protecting fundamental rights on the one hand and promoting innovation on the other, coherence and simplicity have been partially disregarded, the authors said when presenting the […]

Eugenie Ankowitsch Published: February 10th, 2022

Health data: ethics before profit

The European Health Data Space (EHDS) is to be created by 2025. The French EU Council Presidency has presented guiding principles in advance as an ethical framework for digitization in healthcare.In February 2020, the EU Commission adopted the European Data Strategy. The health data space envisaged as part of this strategy is intended to make […]

Eugenie Ankowitsch Published: February 4th, 2022

04.02.2022_Edi

The current gas price crisis continues to preoccupy the European Union’s top politicians. In the view of Luxembourg’s Energy Minister Claude Turmes, only a package of measures will help: increase energy efficiency, expand renewable energies and diversify gas sources. The demand for gas will continue to fall. From a climate policy perspective, gas also has […]

Eugenie Ankowitsch Published: February 3rd, 2022

Health data: ethics framework initiative launched

The French Council Presidency wants to develop an ethical framework as the basis for the planned European Health Data Space. The initiative was launched at the “Citizenship, Ethics and Health Data” conference. The goals pursued with the creation of the European Health Data Space (EHDS) cannot be achieved without the trust of citizens, stressed French […]

Eugenie Ankowitsch Published: February 2nd, 2022

Product liability and AI: Commission working on new rules

The Product Liability Directive applies to all moving products regardless of the technology they use, and therefore actually also to AI-controlled products. It is intended to provide protection at a level not covered by national fault-based liability alone. It establishes a system of strict liability for the manufacturer.However, an evaluation commissioned by the EU Commission […]

Eugenie Ankowitsch Published: January 31st, 2022

31.01.22_Editorial

Following massive pressure from the US calling for sanctions against the controversial Nord Stream 2 Baltic Sea pipeline and the Russian energy and financial sectors, Brussels and Washington are now preparing for a possible interruption in gas supplies from Russia together. The search for alternatives to Russian gas is in full swing. However, transatlantic cooperation […]

Eugenie Ankowitsch Published: January 28th, 2022

Health data: Finland as a blueprint?

In February 2020, the EU Commission adopted the European Data Strategy. The Health Data Space envisaged in this framework is intended, for example, to enable the exchange of electronic patient records, genomics data, or data from patient registers safely across the borders of EU countries in accordance with uniform standards. The aim is not only […]

Eugenie Ankowitsch Published: January 26th, 2022

Robert Habeck made his inaugural visit to Brussels yesterday to meet with Ursula von der Leyen and half a dozen of her commissioners. The Green politician said that Germany should vote against the supplementary legal act on taxonomy in its current form, although this was his “personal-political opinion”. The statement says a lot about the […]

Eugenie Ankowitsch Published: January 25th, 2022

Liese: no supply contracts for COVID drug Paxlovid

It is expected that on Thursday, the European Medicines Agency (EMA) will decide whether to approve Pfizer’s COVID drug Paxlovid. This was said by Peter Liese, a member of the EU Parliament, in an interview with journalists. He expects that after a positive EMA vote, the EU Commission will formally approve the drug on the […]